Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 7, 2011 - Issue
Submit an article Journal homepage
73
Views
9
CrossRef citations to date
0
Altmetric
Review

If you don’t take it – it can’t work: the consequences of not being treated or nonadherence to osteoporosis therapy

Jonathan D Adachi1 Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, CanadaCorrespondence[email protected]
,
Robert G Josse2 Osteoporosis Center, Division of Endocrinology and Metabolism St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
&
R Graham G Russell3 Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, Oxford University Institute of Musculoskeletal Sciences (The Botnar Research Centre), Nuffield Orthopaedic Center, Oxford, UK;4 The Mellanby Center For Bone Research, Department of Human Metabolism, The University of Sheffield Medical School, Sheffield, UK
Pages 181-198 | Published online: 24 May 2011

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Michael Pazianas, Bo Abrahamsen, Serge Ferrari & R Graham G Russell. (2013) Eliminating the need for fasting with oral administration of bisphosphonates. Therapeutics and Clinical Risk Management 9, pages 395-402.
Read now
Doreen Matsui. (2013) Medication adherence issues in patients: focus on cost. Clinical Audit 5, pages 33-42.
Read now
Robert Josse, Aliya Khan, Daniel Ngui & Marla Shapiro. (2013) Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis. Current Medical Research and Opinion 29:3, pages 205-216.
Read now

Articles from other publishers (6)

Kristin K. Clemens, Nivethika Jeyakumar, Alexandra M. Ouédraogo, Jenny Thain & Tayyab Khan. (2020) Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study. Archives of Osteoporosis 15:1.
Crossref
Patricia Seuffert, Carlos A. Sagebien, Matthew McDonnell & Dorene A. O′Hara. (2016) Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice. Archives of Osteoporosis 11:1.
Crossref
Gemma Di Pompo, Ferruccio Poli, Manuela Mandrone, Beatrice Lorenzi, Laura Roncuzzi, Nicola Baldini & Donatella Granchi. (2014) Comparative “in vitro” evaluation of the antiresorptive activity residing in four Ayurvedic medicinal plants. Hemidesmus indicus emerges for its potential in the treatment of bone loss diseases. Journal of Ethnopharmacology 154:2, pages 462-470.
Crossref
L. Bondo, P. Eiken & B. Abrahamsen. (2012) Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study. Osteoporosis International 24:1, pages 245-252.
Crossref
Steven Boonen, Richard Eastell, Guoqin Su, Peter Mesenbrink, Felicia Cosman, Jane A Cauley, Ian R Reid, Frank Claessens, Dirk Vanderschueren, Kenneth W Lyles & Dennis M Black. (2012) Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis. Journal of Bone and Mineral Research 27:7, pages 1487-1493.
Crossref
Rozalia Dimitriou, Giorgio Maria Calori & Peter V Giannoudis. (2012) Improving patients’ outcomes after osteoporotic fractures. International Journal of Clinical Rheumatology 7:1, pages 109-124.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.